DCU researchers develop a molecular sensor that will assist in healthcare tests for cancer and diabetes

EU-funded researchers at DCU working on the Receptor Doped Gels project have developed an improved, low-cost, bio-compatible molecular sensors. The new Receptor Doped Gels address previous problems in bio-compatible sensor designs. The new system allows for the target and monitoring of important ions present in the blood like calcium, potassium and sodium. These are parameters are critical for the monitoring of ill patients. The “iongel” (IL) sensors were integrated into lab on a disc microfluidic technology that allows for multiple analysis in situ.

The research was undertaken by DCU researchers (CLARITY/INSIGHT) Dr. Kevin Fraser and Prof Dermot Diamond.